Skip to main content
. 2022 May 23;20(4):289–298. doi: 10.18502/ijrm.v20i4.10900

Table 3.

Comparison of variable outcomes before and after intervention in study groups


Variables Treatment group Control group
Body mass index*
Before 31.32 ± 5.8686 30.27 ± 4.9530
After 30.82 ± 5.9531 29.55 ± 5.0921
P-value < 0.001 < 0.001
Fasting blood glucose*
Before 91.41 ± 10.635 85.82 ± 12.519
After 89.91 ± 8.326 85.18 ± 11.236
P-value 0.261 0.496
Fasting insulin levels (days)**
Before 20.28 (14.34) 16.68 (9.42)
After 15.82 (11.40) 15.41 (10.67)
P-value 0.042 0.661
HOMA-IR index**
Before 4.49 (3.73) 3.27 (1.88)
After 3.67 (3.28) 3.36 (2.52)
P-value 0.014 0.592
*Data presented as Mean ± Standard deviation, Paired t test. **Data presented as median (IQR), Wilcoxon Test. HOMA-IR: Homeostatic model assessment for insulin resistance